SpaceX CRS-35 planned to carry NASA experiments to International Space Station
Planned mission includes supplies, solar arrays, and studies of brain models, crops, and drug-resistant bacteria.
- SpaceX CRS-35 is the 35th planned Commercial Resupply Services mission to the International Space Station.
- The mission is planned to launch from Cape Canaveral Space Force Station with supplies, iROSAs and NASA experiments.
- One NASA experiment uses lab-grown human brain models to study cellular effects of spaceflight over five weeks.
- A crop disease study will compare infected Earth-grown plants with space station-grown plants to assess fungal disease progression in microgravity.
- The payload also tests a compact microplate reader and studies drug-resistant bacteria on the space station.
What happened
SpaceX CRS-35 is a planned mission to the International Space Station. It is the 35th Commercial Resupply Services mission and is planned to launch from Cape Canaveral Space Force Station. Its payload includes supplies, International Space Station Roll-Out Solar Arrays (iROSAs), and NASA experiments.
What we know
CRS-35 is planned as the 35th Commercial Resupply Services mission associated with SpaceX. The mission's destination is the International Space Station, and its launch site is Cape Canaveral Space Force Station.
The payload includes supplies, International Space Station Roll-Out Solar Arrays (iROSAs), and NASA experiments centered on human health, plant health, and drug-resistant organisms.
One payload is 3D models of the human brain. The new precision health investigation includes small, lab-grown brain models and work over 5 weeks to study the cellular effects of a short spaceflight on the human brain. The precision health investigation is listed with a status of fourth and final planned stay.
A crop disease study examines whether plant diseases progress faster and more severely in microgravity. It compares infected Earth-grown plants with space station-grown plants, looking at molecular and structural changes tied to a disease-causing fungus.
The planned flight includes a faster way to assess astronaut health and the first test of a compact microplate reader. The reader arrived aboard the space station earlier this year. A Commercially Enabled Rapid Space Science initiative experiment is intended to detect and measure biomarkers such as antibodies, antigens, and proteins. The reader can analyze samples aboard the station and obtain data quickly, supporting prompt detection of infections and other astronaut health issues.
A separate precision health investigation analyzes antibiotic-resistant bacteria and how drug-resistant organisms survive and evolve in microgravity. Astronauts repeatedly take surface samples across the space station to monitor these organisms. The work supports astronaut health during long-duration missions.
Why it matters
For readers tracking the lunar industry, the mission matters because it tests capabilities tied to long-duration missions: rapid astronaut-health assessment, crop disease research, and monitoring of drug-resistant organisms. These issues affect crew health and extended missions.
The space crops work also matters because crops can provide nutrition, increase dietary variety, offer psychological benefits during extended missions, absorb carbon dioxide, produce oxygen, and recycle water. The investigation could guide disease-resistant plant breeding on Earth and help minimize yield losses in future space agriculture systems.
Sources
Written by AI systems from the sources above and checked automatically; no personal byline. How this site works